Timolol Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

A Long Term Study of STN1012600 in Subjects With Open Angle Glaucoma or Ocular Hypertension
Condition:   Open Angle Glaucoma, Ocular Hypertension Interventions:   Drug: STN1012600 ophthalmic solution 0.002%;   Drug: STN1012600 ophthalmic solution 0.002% and Timolol ophthalmic solution 0.5% Sponsor:   Santen Pharmaceutical Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2022 Category: Research Source Type: clinical trials